Skip to main content

Decreased Incidence of Stings in Venom-Sensitive Patients Following Venom Immunotherapy

Buy Article:

$31.50 plus tax (Refund Policy)

We re-questioned 23 patients from our Venom Referral Clinic after three or more years of venom immunotherapy to determine whether venom immunotherapy makes venom-sensitive patients less susceptible to future stings. They were asked the same questions regarding stings, including: The number of stings in the previous 2 years, insects involved, time spent out of doors per week, and avoidance techniques. The number of patients stung in the previous 2 years dropped from 87% to 30%. Furthermore, the mean number of stings in 2 years per subject was 1.30 compared to 2.26 prior to these patients receiving venom immunotherapy. The average number of hours spent out of doors for this group of patients increased from 16.7 hrs per week to 18.9 hrs per week. Therefore, these patients were stung less frequently despite spending somewhat more time out of doors. We conclude that the process of desensitization during venom immunotherapy makes venom-sensitive patients less susceptible to future stings.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Publication date: 1994-03-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more